![These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997 These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=c080f728-figure-03.jpg&id=407088)
These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997
![These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997 These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=c080f728-figure-02.jpg&id=407088)
These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997
![Wound closure is accelerated by treatment with topical NTX or Regranex... | Download Scientific Diagram Wound closure is accelerated by treatment with topical NTX or Regranex... | Download Scientific Diagram](https://www.researchgate.net/publication/316464020/figure/fig1/AS:540459215921152@1505866926538/Wound-closure-is-accelerated-by-treatment-with-topical-NTX-or-Regranex-O-A-Photographs.png)
Wound closure is accelerated by treatment with topical NTX or Regranex... | Download Scientific Diagram
![PDF) Integrating the Results of Phase IV (Postmarketing) Clinical Trial With Four Previous Trials Reinforces the Position that Regranex (Becaplermin) Gel 0.01% Is an EffectiveAdjunct to the Treatment of Diabetic Foot Ulcers PDF) Integrating the Results of Phase IV (Postmarketing) Clinical Trial With Four Previous Trials Reinforces the Position that Regranex (Becaplermin) Gel 0.01% Is an EffectiveAdjunct to the Treatment of Diabetic Foot Ulcers](https://i1.rgstatic.net/publication/237748250_Integrating_the_Results_of_Phase_IV_Postmarketing_Clinical_Trial_With_Four_Previous_Trials_Reinforces_the_Position_that_Regranex_Becaplermin_Gel_001_Is_an_EffectiveAdjunct_to_the_Treatment_of_Diabetic/links/0a85e52e7b8a5d7ec4000000/largepreview.png)
PDF) Integrating the Results of Phase IV (Postmarketing) Clinical Trial With Four Previous Trials Reinforces the Position that Regranex (Becaplermin) Gel 0.01% Is an EffectiveAdjunct to the Treatment of Diabetic Foot Ulcers
![Lens and Meds on X: "Becaplermin is a gel applied topically to diabetic ulcers on the lower limbs (foot, ankle, and leg) to promote healing of the ulcers. . #pharmacy #neet #mbbs # Lens and Meds on X: "Becaplermin is a gel applied topically to diabetic ulcers on the lower limbs (foot, ankle, and leg) to promote healing of the ulcers. . #pharmacy #neet #mbbs #](https://pbs.twimg.com/media/E7kEc3tVkAA0rEb.jpg:large)